W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

Al Ahram Weekly reports on the variety and sophistication of the products on display at this year’s Egypt Defence Industries Exhibition The fourth edition of the Egypt Defence Industries Exhibition ...

EDEX 2025 marked the most mature and technologically ambitious phase of Egypt’s defence-industrial showcase since the exhibition’s launch in 2018, reflecting a steady transformation in the country’s ...

The Sakr 105 rocket launcher displayed on the Arab International Optronics stand at EDEX 2025. (Janes/Jeremy Binnie) Egypt's state-owned Arab Organisation for Industrialisation (AOI) displayed a ...

The Egyptian Air Defense Forces (EADF) is using the Thales Ground Master 403 (GM403) long-range surveillance radar, it was confirmed during the Egypt Defence Expo (EDEX) 2025 held in Cairo from 1 to 4 ...

The study met the primary endpoint, demonstrating a complete response of 89% in the ondansetron extended release injection arm vs 82% in the standard ondansetron injection arm. Topline data were ...

FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is ...

According to Lilly, the single-injection, citrate-free, maintenance dose will be available in the US as a prefilled pen or prefilled syringe in early 2026. The Food and Drug Administration (FDA) has ...

This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ...

ASC30 is an investigational GLP-1 receptor (GLP-1R) biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous ...